Respiratory Treatment and Prevention (Advances in Experimental Medicine and Biology)

(Jacob Rumans) #1

Table 4 Symptoms in patients with and without malaria


Malaria (n¼15) (%) No malaria (n¼38) (%) p-value
Fever 12 (80.0) 18 (47.4) 0.031
Headache 3 (20.0) 9 (23.7) 0.550
Cough 1 (6.7) 3 (7.9) 0.879
Sickness 3 (20.0) 7 (18.4) 0.895
Vomit 3 (20.0) 2 (5.3) 0.098
Diarrhea 3 (20.0) 8 (21.1) 0.932
Chills 6 (40.0) 6 (15.8) 0.058
Body ache 2 (13.3) 5 (13.2) 0.986
Dizziness 2 (13.3) 1 (2.6) 0.129
Weakness 1 (6.7) 0 0.108
Sweats 1 (6.7) 5 (13.2) 0.502
Fatigue 6 (40.0) 8 (21.1) 0.159
Custom cramps 1 (6.7) 0 0.108
Night sweats 1 (6.7) 0 0.108
Dark urine 1 (6.7) 0 0.108
Weight loss 1 (6.7) 0 0.108
Cold sweats 1 (6.7) 0 0.108
Lymph node swelling 1 (6.7) 0 0.108
Reduced general condition 1 (6.7) 0 0.108
Impaired consciousness 1 (6.7) 0 0.108
Brown sputum 0 2 (5.3) 0.365
Pollakiuria 0 1 (2.6) 0.526
Shortness of breath 0 1 (2.6) 0.526
Sore throat 0 2 (5.3) 0.365

Table 5 Geographic origin of malaria in patients who brought it over from faraway destinations and in those in who
malaria was excluded


Malaria (n¼15) (%) No malaria (n¼38) (%)
Peru 0 1 (2.6)
Ghana 5 (33.3) 2 (5.3)
Thailand 0 6 (15.8)
Togo 2 (13.3) 0
Tanzania 2 (13.3) 0
Congo 1 (6.7) 1 (2.6)
Benin 2 (13.3) 0
Aswan 1 (6.7) 0
Nigeria 1 (6.7) 1 (2.6)
Indonesia 1 (6.7) 0
Brazil 0 1 (2.6)
Dominican Republic 0 1 (2.6)
Asia 0 1 (2.6)
Kenya 0 3 (7.9)
India 0 2 (5.3)
Ecuador 0 1 (2.6)
Egypt 0 2 (5.3)
Other 0 16 (42.1)

Rarity of Mixed Species Malaria withPlasmodium falciparumand... 41

Free download pdf